Devices and therapeutics for preterm labor prevention
Total Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
1,898
NCT01306929
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 24, 2011
Completion: Jan 5, 2018
NCT02006472
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Start: Feb 28, 2014
Completion: Jul 7, 2016
NCT02494778
A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
Start: Sep 24, 2015
Completion: Jan 12, 2018
NCT03019289
A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease
Phase: Phase 1
Start: Apr 19, 2017
Completion: Feb 9, 2018
NCT03922711
A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Start: May 22, 2019
Completion: Jul 22, 2020
NCT04556656
PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD
Phase: Phase 3
Start: Oct 16, 2020
Completion: Mar 21, 2024
NCT04615923
HEALEY ALS Platform Trial - Regimen D Pridopidine
Phase: Phase 2/3
Role: Collaborator
Start: Dec 18, 2020
Completion: Jul 14, 2022
NCT04132401
AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care
Phase: N/A
Start: May 1, 2021
Completion: Sep 26, 2023
NCT05166733
A Retrospective Study of Reco Thrombectomy Stent for Intravascular Treatment of Acute Ischemic Stroke
Start: Dec 31, 2021
Completion: Dec 31, 2022
Loading map...